Primus Therapeutics Inc. — Form D
Primus Therapeutics Inc. of SKILLMAN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2011-02-16. The offering totals $1.0M, of which $300K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-02-16
- Form: D
- Accession: 0001501467-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $300K
- Remaining: $700K
- Investors: 2
- Date of first sale: 2011-01-25
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-155455
Issuer
- Name: Primus Therapeutics Inc.
- CIK: 0001501467
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 23 ORCHARD ROAD, SKILLMAN, NJ, 08558
- Phone: 800-903-4131
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Joseph Falsetti | Director | Skillman, NJ |
| Robert Hariri | Director | Scottsdale, AZ |
| Dennis O'Donnell | Director | Skillman, NJ |
| Andrew Sadosky | Director | Skillman, NJ |
| Kenneth Taylor | Director | Skillman, NJ |
| Mark Massad | Executive Officer | Skillman, NJ |
| Dennis O'Donnell | Executive Officer | Skillman, NJ |
Other filings by this issuer (1)
More